Pieter Wesseling
Overview
Explore the profile of Pieter Wesseling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
265
Citations
20285
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aldape K, Capper D, von Deimling A, Giannini C, Gilbert M, Hawkins C, et al.
Neurooncol Adv
. 2025 Feb;
7(1):vdae228.
PMID: 39902391
Genome-wide DNA methylation signatures correlate with and distinguish central nervous system (CNS) tumor types. Since the publication of the initial CNS tumor DNA methylation classifier in 2018, this platform has...
2.
Hinz F, Friedel D, Korshunov A, Ippen F, Bogumil H, Banan R, et al.
Acta Neuropathol
. 2025 Feb;
149(1):12.
PMID: 39899075
IDH-mutant astrocytomas are diffuse gliomas that are defined by characteristic mutations in IDH1 or IDH2 and do not have complete 1p/19q co-deletion. The established grading criteria include histological features of...
3.
van Hijfte L, Geurts M, de Heer I, Ghisai S, Balcioglu H, Hoogstrate Y, et al.
Nat Commun
. 2025 Jan;
16(1):1156.
PMID: 39880824
Isocitrate dehydrogenase 1/2 mutant (IDHmt) astrocytoma is considered a T cell-deprived tumor, yet little is known regarding the phenotypes underlying T cell exclusion. Using bulk, single nucleus and spatial RNA...
4.
Kooi E, Marcelis L, Wesseling P
Pathology
. 2025 Jan;
57(2):144-156.
PMID: 39818455
In the course of the last decade, the pathological diagnosis of many tumours of the central nervous system (CNS) has transitioned from a purely histological to a combined histological and...
5.
Schmid S, Mirchia K, Tietze A, Liu I, Siewert C, Nuckles J, et al.
Neuro Oncol
. 2024 Dec;
PMID: 39713960
Background: Intracerebral schwannomas are rare tumors resembling their peripheral nerve sheath counterparts but localized in the CNS. They are not classified as a separate tumor type in the 2021 WHO...
6.
Wallis F, Baker-Hernandez J, van Tuil M, van Hamersveld C, Koudijs M, Verwiel E, et al.
EBioMedicine
. 2024 Dec;
111:105506.
PMID: 39709770
Background: With many rare tumour types, acquiring the correct diagnosis is a challenging but crucial process in paediatric oncology. Historically, this is done based on histology and morphology of the...
7.
Sahm F, Bertero L, Brandner S, Capper D, Goldbrunner R, Jenkinson M, et al.
Neuro Oncol
. 2024 Nov;
PMID: 39577862
Meningiomas are the most common primary intracranial tumors of adults. For meningiomas that progress or recur despite surgical resection and radiotherapy, additional treatment options are limited due to lack of...
8.
Tauziede-Espariat A, Friker L, Nussbaumer G, Bison B, Dangouloff-Ros V, Metais A, et al.
Acta Neuropathol Commun
. 2024 Nov;
12(1):176.
PMID: 39558399
Diffuse pediatric-type high-grade gliomas (pedHGG), H3- and IDH-wildtype, encompass three main DNA-methylation-based subtypes: pedHGG-MYCN, pedHGG-RTK1A/B/C, and pedHGG-RTK2A/B. Since their first description in 2017 tumors of pedHGG-RTK2A/B have not been comprehensively...
9.
Azizova A, Prysiazhniuk Y, Wamelink I, Cakmak M, Kaya E, Wesseling P, et al.
Eur Radiol
. 2024 Oct;
35(3):1242-1254.
PMID: 39425768
Objectives: To develop a gadolinium-free MRI-based diagnosis prediction decision tree (DPDT) for adult-type diffuse gliomas and to assess the added value of gadolinium-based contrast agent (GBCA) enhanced images. Materials And...
10.
van den Bent M, Franceschi E, Touat M, French P, Idbaih A, Lombardi G, et al.
Neuro Oncol
. 2024 Oct;
27(2):331-337.
PMID: 39387386
The standard of care for adult patients with gliomas, glioneuronal, and neuronal tumors consists of combinations of surgery, radiotherapy, and chemotherapy. For many systemic cancers, targeted treatments are a major...